TherapeuticsMD (TXMD) Enterprise Value (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Enterprise Value came in at -$8.4 million in Q1 2026, down 46.54% YoY from -$15.7 million in Q1 2025, and down 12.51% on a QoQ basis from -$7.5 million in Q4 2025.
TherapeuticsMD (TXMD) Enterprise Value (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Enterprise Value data on file, last reported at -$8.4 million in Q1 2026.
- Quarterly Enterprise Value fell 46.54% year-over-year to -$8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.4 million (down 46.54% YoY) and the FY2025 annual result came in at -$7.5 million, down 47.91% from the prior year.
- Enterprise Value declined to -$8.4 million in Q1 2026, from -$7.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.3 million in Q4 2023 to a low of -$60.6 million in Q4 2022.
- A 5-year average of -$17.0 million and a median of -$7.5 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 92.86% — and 2025, when it sank 47.91%.
- Tracing TXMD's Enterprise Value over 5 years: stood at -$60.6 million in 2022, then soared by 92.86% to -$4.3 million in 2023, then decreased by 16.92% to -$5.1 million in 2024, then slumped by 47.91% to -$7.5 million in 2025, then slipped by 12.51% to -$8.4 million in 2026.
- The last three Enterprise Value figures came in at -$8.4 million (Q1 2026), -$7.5 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -9.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.19 Mn |
| Mar 31, 2026 | -8.42 Mn |
| Dec 31, 2025 | -7.48 Mn |
| Sep 30, 2025 | -7.12 Mn |
| Jun 30, 2025 | -6.07 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Dec 31, 2024 | -5.06 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Jun 30, 2024 | -5.23 Mn |
| Mar 31, 2024 | -4.34 Mn |
| Dec 31, 2023 | -4.33 Mn |
| Sep 30, 2023 | -10.17 Mn |
| Jun 30, 2023 | -13.73 Mn |
| Mar 31, 2023 | -17.25 Mn |
| Dec 31, 2022 | -60.57 Mn |
| Sep 30, 2022 | -49.58 Mn |
| Jun 30, 2022 | -48.80 Mn |
| Mar 31, 2022 | -30.38 Mn |
| Dec 31, 2021 | -64.91 Mn |
| Sep 30, 2021 | -104.84 Mn |